Cell‐free protein synthesis: The transition from batch reactions to minimal cells and microfluidic devices
MH Ayoubi‐Joshaghani… - Biotechnology and …, 2020 - Wiley Online Library
Thanks to the synthetic biology, the laborious and restrictive procedure for producing a
target protein in living microorganisms by biotechnological approaches can now experience …
target protein in living microorganisms by biotechnological approaches can now experience …
Microfluidic reactor with immobilized enzyme-from construction to applications: A review
H Zhang, Y Bai, N Zhu, J Xu - Chinese Journal of Chemical Engineering, 2021 - Elsevier
Microfluidic, as the systems for using microchannel (micron-or sub-micron scale) to process
or manipulate microflow, is being widely applied in enzyme biotechnology and biocatalysis …
or manipulate microflow, is being widely applied in enzyme biotechnology and biocatalysis …
Moving protein PEGylation from an art to a data science
PEGylation is a well-established and clinically proven half-life extension strategy for protein
delivery. Protein modification with amine-reactive poly (ethylene glycol)(PEG) generates …
delivery. Protein modification with amine-reactive poly (ethylene glycol)(PEG) generates …
Development and Characterization of a Portable Flow Microreactor for Enhanced Bioconjugation Applications
Y Endo, Y Nakahara, R Shiroma… - … Process Research & …, 2024 - ACS Publications
The reliance of pharmaceutical production on batch reactors dating back to the 20th century
has exposed vulnerabilities in the supply chains of essential medicines, which were …
has exposed vulnerabilities in the supply chains of essential medicines, which were …
Development of an integrated continuous PEGylation and purification process for granulocyte colony stimulating factor
N Kateja, S Dureja, AS Rathore - Journal of Biotechnology, 2020 - Elsevier
PEGylation of therapeutic proteins has long been recognized as a safe and effective
approach to enhance pharmacokinetic properties of proteins by increasing the in-vivo half …
approach to enhance pharmacokinetic properties of proteins by increasing the in-vivo half …
Fatty acid chain modification of loxenatide and its kinetics in a continuous flow microchannel reactor
SC Wang, XD Wang, XN Teng, JY Dai, YS Dong… - Process …, 2023 - Elsevier
In this study, a continuous flow microchannel reactor was designed and constructed for
continuous and efficient fatty acid chain modification (FACylation) of polypeptides to achieve …
continuous and efficient fatty acid chain modification (FACylation) of polypeptides to achieve …
A Manufacturing Strategy Utilizing a Continuous-Mode Reactor toward Homogeneous PEGylated Bioconjugate Production
Y Nakahara, Y Endo, K Takahashi, T Kawaguchi… - …, 2024 - thieme-connect.com
Protein PEGylation is a traditional bioconjugation technology that enhances the therapeutic
efficacy and in vivo half-life of proteins by the formation of covalent bonds with highly …
efficacy and in vivo half-life of proteins by the formation of covalent bonds with highly …
Microfluidics in protein engineering
Protein engineering has gained significant attention worldwide. Cell-based protein synthesis
is tedious and takes a long time to synthesize the desired protein. Microfluidics is an …
is tedious and takes a long time to synthesize the desired protein. Microfluidics is an …
A process for preparation of pegylated therapeutic proteins
AS Rathore, N Kateja - US Patent App. 17/782,161, 2023 - Google Patents
The present invention provides a novel process of PEGy lation and purification of the
PEGylated therapeutic pro teins. The developed PEGylation protocol provides high yield of …
PEGylated therapeutic pro teins. The developed PEGylation protocol provides high yield of …